Sundaram N.M. and Mangala Prasad V. 2026. Using electron microscopy to observe ultrastructural changes occurring during cellular infection by Japanese encephalitis virus. Biochemical and Biophysical Research Communications 819:153814.
Rudramurthy G.R., Gudla C.S., Harisha R., Selvam V., Vijayakumar L.K., Kailaje V., Naveenkumar C., Bharathkumar K., Shanmugam S., Narayan R., Kanojia A., Tripathi S., Roy A., Mangala Prasad V., Sharad T., Shivaprasad S., Kondreddi R.R., Singh M, Shandil R.K., Narayanan S. 2026. FNDR-11124, a broad-spectrum small molecule inhibitor of viral RNA polymerase, restricts replication of SARS-CoV-2 and Influenza virus in vitro and in vivo. Antiviral Research 106382, ISSN 0166-3542.
Sharma P., Tanwar M., Choudhary E., Sundaram N.M., Ojha D., Mishra L., Nain M., Rode A., Mangala Prasad V., Vrati S., Kalia M. 2025. Endophilin mediated endocytosis and Epidermal growth factor receptor govern Japanese encephalitis virus entry and infection in neuronal cells. Plos Pathogens 21(12):e1013790.
Sharma P., Pallavi A., Chatterjee A., Mangala Prasad V., Gandasi N., Saroja S.R. 2025. Impaired MAPT/tau-secretory lysosomes are linked to cognitive vulnerability in Alzheimer patients. Autophagy (12):3024-3038.
Ahuja R.#, Vishwakarma P.#, Kumar V., Khatri R., Chatterjee A., Mishra S., Rizvi Z.A., Singh A., Kaur G., Maithil V., Tarane K., Chauhan A., Singh S., Yadav P., Yadav D., Sinha S.K., Ali S.K., Chatterjee A., Priyadarsiny P., Awasthi A., Mangala Prasad V., Ahmed S.*, Samal S*. 2025. Next-Gen Novel Nanocage-based Multivalent Vaccine candidate to tackle the Rising Menace of Mpox. Npj Vaccine 10, 117.
Gupta R.£, Sharma S.£, Saroj A., Madhukalya R., Kumar V., Agarwal V., Kumar D., Mangala Prasad V.*, Kumar R.*. 2025. Kyasanur Forest disease virus non-structural protein NS1 forms multimers in solution, with a distinctly identifiable tetrameric state. Biochimie 234:89-94. shared corresponding author
Makam A.A., Sharma S., Nagle P., Sundaram N.M, Mangala Prasad V., Gandasi N.R. 2024. tPA-GFP is a reliable probe for detecting compound exocytosis in human pancreatic β-cells. FASEB Bioadvances 7(2):e1482.
Veerabhadraswamy P., Lata K., Dey S., Belekar P., Kothegala L., Mangala Prasad V., Gandasi N.R. 2024. Localization and release of multivesicular bodies that secrete exosomes in islet cells: dysregulation during type-2 diabetes. Journal of Extracellular Biology, 3(11):e70014.
Pandey B., Srividhya S., Chatterjee A., Mangala Prasad V., 2023. Role of surface glycans in enveloped RNA virus infections: A structural perspective. Proteins, doi: 10.1002/prot.26636.
Hodge E.A., Chatterjee A., Chen C., Naika G.S., Laohajaratsang M., Mangala Prasad V.* and Lee K.K.*. 2023. An HIV-1 broadly neutralizing antibody overcomes structural and dynamic variation through highly focused epitope targeting. NPJ Viruses, 1(2).
Lata K., Charles S., and Mangala Prasad V. 2023. Advances in computational approaches to structure determination of alphaviruses and flaviviruses using cryo-electron microscopy. Journal of Structural Biology, 215(3):107993.
Pre-IISc:
Roier S., Mangala Prasad V., McNeal M.M., Lee K.K., Petsch B. and Rauch S. 2023. Novel mRNA-based VP8* vaccines against rotavirus are highly immunogenic in rodents. NPJ Vaccines, 8(1):190.
Mangala Prasad V., Blijleven J., Smit J.M. and Lee K.K. 2022. Visualization of conformational changes and membrane remodeling leading to genome delivery by viral class-II fusion machinery. Nature Communications, 13, 4772.
Mangala Prasad V., Leaman D.P., Lovendahl K.N., Croft J.T., Benhaim M.A., Hodge E.A., Zwick M.B., and Lee K.K. 2022. Cryo-ET of Env on intact HIV virions reveals structural variation and positioning on the Gag lattice. Cell, 185:1-13.
Aljedani SS, Liban TJ, Tran K, Phad G, Singh S, Dubrovskaya V,..., Mangala Prasad V. et al. 2021. Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization. PLoS Pathog., 17(9): e1009543.
Shipley M.M.*, Mangala Prasad V.*, Dingens A., Ralph D., Harkins E., Doepker L.E., Dhar A., Arenz D., Vigdorovich V., Chohan V.,Sather N., Jesse D. Bloom J.D., Matsen F.A., Lee K.K. and Overbaugh J.M. 2021. Functional development of a V3-specific broadly neutralizing antibody isolated from a case of HIV-1 superinfection. eLife 2021;10:e68110, *shared first author.
Benhaim M., Mangala Prasad V., Garcia N.K., Guttman M., and Lee K.K. 2020. Structural monitoring of a transient intermediate in the hemagglutinin fusion machinery on influenza virions. Science Advances, 6(18):eaaz8822.
Simonich C.A., Doepker L., Ralph D., Williams J.A., Dhar A., Yaffe Z., Gentles L., Small C.T., Oliver B., Vigdorovich V., Mangala Prasad V., Nduati R., Sather D.N., Lee K.K., Matsen F.A., Overbaugh J. 2019. Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage. Nature Communications, 10, 2190.
Mangala Prasad V., Klose T., and Rossmann M.G. 2017. Assembly, Maturation and Three Dimensional Structure of Rubella Virus. PloS Pathogens,13(6):1006377.
Mangala Prasad V.,Miller A.S., Klose T., Sirohi D., Buda G., Jiang W., Kuhn R.J., and Rossmann M.G. 2017. Structure of the immature Zika virus at 9Å resolution. Nature Structural and Molecular Biology, 24:184-186.
Porta J., Mangala Prasad V., Akahata W., Ng L., and Rossmann M.G. 2016. Structural Studies of Chikungunya Virus-like Particles Complexed with Human Antibodies: Neutralization and Cell-to-Cell Transmission. Journal of Virology, 90(3):1169-1177.
Mangala Prasad V., Willows S.D., Fokine A., Battisti A.J., Sun S., Plevka P., Hobman T.C., and Rossmann M.G. Rubella virus capsid protein structure and its role in virus assembly and infection. 2013. Proceedings of the National Academy of Sciences (PNAS), 110(50):20105–20110.
Battisti A.J., Yoder J.D., Plevka P., Winkler D.C., Mangala Prasad V., Kuhn R.J., Frey T.K., Steven A.C., and Rossmann M.G. 2012. Cryo-Electron Tomography of Rubella Virus. Journal of Virology, 86(20):11078-85.